These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9631992)

  • 21. Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
    Elewski BE; Aly R; Baldwin SL; González Soto RF; Rich P; Weisfeld M; Wiltz H; Zane LT; Pollak R
    J Am Acad Dermatol; 2015 Jul; 73(1):62-9. PubMed ID: 25956661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nail incorporation kinetics of terbinafine in onychomycosis patients.
    Schatz F; Bräutigam M; Dobrowolski E; Effendy I; Haberl H; Mensing H; Weidinger G; Stütz A
    Clin Exp Dermatol; 1995 Sep; 20(5):377-83. PubMed ID: 8593713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
    Gupta AK; Fleckman P; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
    Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
    Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy of once-weekly fluconazole (100, 150, or 300 mg) with topical application of ketoconazole cream in the treatment of onychomycosis.
    Chen X; Hiruma M; Shiraki Y; Ogawa H
    Jpn J Infect Dis; 2004 Dec; 57(6):260-3. PubMed ID: 15623951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail.
    Elewski B; Brand S; Degenhardt T; Curelop S; Pollak R; Schotzinger R; Tavakkol A
    Br J Dermatol; 2021 Feb; 184(2):270-280. PubMed ID: 32421854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The new oral antifungal agents for onychomycosis of the toenails.
    Gupta AK; Shear NH
    J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
    Elewski BE; Rich P; Pollak R; Pariser DM; Watanabe S; Senda H; Ieda C; Smith K; Pillai R; Ramakrishna T; Olin JT
    J Am Acad Dermatol; 2013 Apr; 68(4):600-608. PubMed ID: 23177180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: a pooled analysis of an 8-week, post-study follow-up from two randomized phase 3 studies.
    Gupta AK; Hall S; Zane LT; Lipner SR; Rich P
    J Dermatolog Treat; 2018 Feb; 29(1):44-48. PubMed ID: 28521541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial.
    Yadav P; Singal A; Pandhi D; Das S
    Indian J Dermatol Venereol Leprol; 2015; 81(4):363-9. PubMed ID: 26087080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tavaborole 5% Topical Solution for the Treatment of Toenail Onychomycosis in Pediatric Patients: Results from a Phase 4 Open-Label Study.
    Rich P; Spellman M; Purohit V; Zang C; Crook TJ
    J Drugs Dermatol; 2019 Feb; 18(2):190-195. PubMed ID: 30811142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study.
    Syed TA; Ahmadpour OA; Ahmad SA; Shamsi S
    J Dermatol; 1998 Oct; 25(10):648-52. PubMed ID: 9830263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis.
    Havu V; Heikkilä H; Kuokkanen K; Nuutinen M; Rantanen T; Saari S; Stubb S; Suhonen R; Turjanmaa K
    Br J Dermatol; 2000 Jan; 142(1):97-102. PubMed ID: 10651701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
    Gupta AK; Pillai R
    J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment.
    Gupta AK; Drummond-Main C; Paquet M
    J Dermatolog Treat; 2013 Feb; 24(1):75-80. PubMed ID: 22694221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis.
    Elewski BE; Scher RK; Aly R; Daniel R; Jones HE; Odom RB; Zaias N; Jacko ML
    Cutis; 1997 Apr; 59(4):217-20. PubMed ID: 9104548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space.
    Elewski BE; Pollak RA; Pillai R; Olin JT
    J Drugs Dermatol; 2014 Nov; 13(11):1394-8. PubMed ID: 25607708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis.
    Willemsen M; De Doncker P; Willems J; Woestenborghs R; Van de Velde V; Heykants J; Van Cutsem J; Cauwenbergh G; Roseeuw D
    J Am Acad Dermatol; 1992 May; 26(5 Pt 1):731-5. PubMed ID: 1316389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluconazole (Fungolon) in the treatment of onychomycoses.
    Zisova LG
    Folia Med (Plovdiv); 2004; 46(3):47-50. PubMed ID: 15819457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.